Docetaxel plus nintedanib versus docetaxel plus placebo in patients with previously treated non-small-cell lung cancer (LUME-Lung 1): a phase 3, double-blind, randomised controlled trial

Overview of attention for article published in Lancet Oncology, January 2014

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (87th percentile)

So far, Altmetric has seen 8 policy documents that reference this research output.

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity, including 4 additional policy documents.